The updated data management procedures under the Genomic Data Sharing policy allow unrestricted access to most NIH-supported studies for health and research purposes while considering potential risk to research participants.
NIAID is encouraging collaborations among bioinformaticians, bioengineers, HIV basic scientists, and HIV clinicians with access to relevant clinical specimens to generate novel single-cell multi-omic approaches to improve our knowledge of HIV persistence.
Apply for funding to support projects that develop and test strategies to engage and retain men along the HIV prevention and care continuum.
We seek multidisciplinary, collaborative teams researching innate and adaptive immune mechanisms that contribute to tumor progression.
To create an alternative pathway for early-stage investigators to earn their first substantial award, NIAID is developing a new initiative using the NIH Director's New Innovator Award (DP2) activity code.
NIH recently introduced a new funding opportunity announcement designation for prospective basic science studies involving human participants, to be called Basic Experimental Studies with Humans (BESH).
If you significantly over- or underestimate your project's budget request, reviewers will take that to mean you don't grasp the scope of the work.
Applicants eligible for continuous submission who send AIDS-related applications on or before February 7, 2019, will be on time for the May 2019 Advisory Council round.
NIH seeks feedback on the definition of Scientific Data and general requirements for Data Management and Sharing Plans.
Learn about the role of scientific review officers, review meeting proceedings, factors reviewers look for in applications, review criteria, scoring of applications, and more.
We’ve now posted interim paylines for most applicable activity codes at NIAID Paylines, including training, fellowship, small business, and small research grant awards.
For more than five decades, NIAID’s Vaccine and Treatment Evaluation Units have been a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases.
Further research is required to translate in vitro findings about antibody-dependent cellular cytotoxicity and antibody-dependent cell-mediated phagocytosis to in vivo efficacy.
Antibodies generated by an anti-opioid vaccine could bind to a target opioid and prevent it from crossing the blood-brain barrier and trafficking to the brain.
Apply now for a cooperative agreement award to develop biomarkers/bioassays, techniques, or devices for use in the civilian population.
We expect successful offerors to provide data-driven, production-level, sustainable computational platforms to enable sharing and access to data, portable computational tools, and standards that support interoperability for the infectious diseases research community.
A concise rundown of the latest news impacting small business concerns seeking small business innovation research or small business technology transfer funding from NIH and NIAID.
NIAID seeks innovative research on innate and adaptive immune responses induced by mycobacterial infection, Bacillus Calmette-Guérin vaccine, or other Mycobacterium tuberculosis vaccinations.
NIAID invites principal investigators to request additional funds to hire a mid-to-senior level technician at a full-time or part-time level of effort to help maintain an eligible postdoctoral scientist’s projects when he or she is required to be away from the lab to fulfill caregiver obligations.
For the first time in 22 years, Congress passed the HHS budget appropriation before the start of the fiscal year.
NIH issued a competitive revisions (Type 3) funding opportunity announcement to accept urgent award applications whenever an NIH institute or center publishes an Urgent Award Notice to define an urgent need in response to a public health crisis.
All NIH new (including renewals) and continuation awards beginning on or after October 1, 2018, are subject to the new final regulations of the Bayh-Dole Act of 1980.
For those who couldn’t make it in person—and those who did but want a refresher—NIH has posted various resources on the Workshop webpage, including the webcast in its entirety.
We recently added two new R01 applications and summary statements. Since these sample applications were submitted using FORMS-D, they fulfill the rigor and reproducibility requirements NIH introduced in 2016.
If you missed the September 17, 2018 meeting of NIAID’s Advisory Council, you can watch a videocast of remarks from NIAID Director Dr. Anthony Fauci and NIAID Division of Intramural Research Director Dr. Steven Holland, as well as open subcommittee sessions.
We highlight three grant opportunities from the Bill and Melinda Gates Foundation that focus on health science topics also of interest to NIAID.
Learn how NIAID staff incorporated community feedback into our strategic plan to advance tuberculosis research and development for the next five years and beyond.
The goal of this request for proposals is to provide mostly non-U.S. laboratories with a comprehensive and uniform approach to evaluating initial and ongoing capability and readiness to carry out NIAID-funded HIV/AIDS clinical trial protocols.
Consider responding to a new request for proposals to establish a Statistical, Data Management and Coordination Center in support of NIAID’s Collaborative Influenza Vaccine Innovation Centers.
NIH's policy on inclusion across the lifespan kicks in for applications due on or after January 25, 2019, and for proposals in response to research and development contract solicitations issued on or after that date.
Two posts from NIH's Open Mike blog imply that an inflection point for improving funding outcomes for underrepresented populations may exist in increasing overall award counts for new and early-stage investigators.
For those investigators whose institutions close due to a natural disaster, such as Hurricane Florence, NIH will consider accepting applications late.
eRA Commons runs an automated check to verify that the eligibility status of an applicant organization matches the submitted application type, which includes the six separate registrations needed to apply for an NIH grant for the first time.
Before NIAID will award you a grant, you must disclose all key personnel’s other projects and funding, including foreign projects and funding, so we can verify there is no scientific, commitment, or budgetary overlap.
Proposed changes to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules would 1) remove the NIH protocol submission, review, and reporting requirements under Appendix M of the NIH Guidelines and 2) modify the roles and responsibilities of the Recombinant DNA Advisory Committee (RAC).
You will not select “Add New Study” and complete Section 3 - Protection and Monitoring Plans in a grant application for a delayed onset study.
The Behavioral and Social Sciences Clinical Trials Template will inform an update to the Clinical e-Protocol Writing Tool, which applicants can use as a guide when preparing comprehensive clinical protocols for Phase 2 and 3 clinical trials.
To apply for the Expanding Extramural Research Opportunities at the NIH Clinical Center funding opportunity announcement, you'll first need to obtain a letter from the Clinical Center director to confirm that the Clinical Center facilities will be able to accommodate your proposed research.
NIAID will now support Academic Research Enhancement Awards focused on undergraduate institutions or academic components in which the undergraduate student enrollment is greater than the graduate student enrollment.
NIAID will help current grantees recruit and support students, postdocs, and other eligible investigators from diverse backgrounds to work on research experiences integral to the grant's ongoing research, with the potential to contribute significantly to the career development of the candidates.